GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alliance Pharma PLC (LSE:APH) » Definitions » Net Margin %

Alliance Pharma (LSE:APH) Net Margin % : 6.28% (As of Jun. 2023)


View and export this data going back to 2001. Start your Free Trial

What is Alliance Pharma Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Alliance Pharma's Net Income for the six months ended in Jun. 2023 was £5.1 Mil. Alliance Pharma's Revenue for the six months ended in Jun. 2023 was £81.4 Mil. Therefore, Alliance Pharma's net margin for the quarter that ended in Jun. 2023 was 6.28%.

The historical rank and industry rank for Alliance Pharma's Net Margin % or its related term are showing as below:

LSE:APH' s Net Margin % Range Over the Past 10 Years
Min: -4.15   Med: 18.5   Max: 28.36
Current: -4.15


LSE:APH's Net Margin % is ranked worse than
64.25% of 1021 companies
in the Drug Manufacturers industry
Industry Median: 3.7 vs LSE:APH: -4.15

Alliance Pharma Net Margin % Historical Data

The historical data trend for Alliance Pharma's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alliance Pharma Net Margin % Chart

Alliance Pharma Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.53 18.44 6.18 4.48 0.56

Alliance Pharma Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.48 -1.09 16.64 -13.73 6.28

Competitive Comparison of Alliance Pharma's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Alliance Pharma's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alliance Pharma's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alliance Pharma's Net Margin % distribution charts can be found below:

* The bar in red indicates where Alliance Pharma's Net Margin % falls into.



Alliance Pharma Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Alliance Pharma's Net Margin for the fiscal year that ended in Dec. 2022 is calculated as

Net Margin=Net Income (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=0.936/167.416
=0.56 %

Alliance Pharma's Net Margin for the quarter that ended in Jun. 2023 is calculated as

Net Margin=Net Income (Q: Jun. 2023 )/Revenue (Q: Jun. 2023 )
=5.109/81.398
=6.28 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alliance Pharma  (LSE:APH) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Alliance Pharma Net Margin % Related Terms

Thank you for viewing the detailed overview of Alliance Pharma's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Alliance Pharma (LSE:APH) Business Description

Traded in Other Exchanges
Address
Bath Road, Avonbridge House, Chippenham, Wiltshire, GBR, SN15 2BB
Alliance Pharma PLC is a player in the healthcare market. The company's business includes the acquisition, marketing, and distribution of consumer healthcare and pharmaceutical products. The group operates in two segments: Consumer Healthcare brands and Prescription Medicines. It generates the majority of its revenue from the Consumer Healthcare segment. Its products include Aloclair, Biodermatin, Changmin, Decapional, Effadiane, and Fazol. The company generates maximum revenue from the Kelo-cote brand. Geographically, it derives a majority of its revenue from Europe, the Middle East, and Africa (EMEA).

Alliance Pharma (LSE:APH) Headlines

From GuruFocus

Q4 2022 Amphenol Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Amphenol Announces Third Quarter 2023 Dividend

By Business Wire 08-04-2023

Q3 2023 Amphenol Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q2 2023 Amphenol Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

The Amphenol Corp (APH) Company: A Short SWOT Analysis

By GuruFocus Research 10-30-2023

Q1 2020 Amphenol Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q1 2021 Amphenol Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q4 2019 Amphenol Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024